Centogene N.V. (CNTGF)
OTCMKTS · Delayed Price · Currency is USD
0.1020
0.00 (0.00%)
Oct 9, 2025, 4:00 PM EDT
Centogene Market Cap
Centogene has a market cap or net worth of $3.03 million as of October 10, 2025. Its market cap has decreased by -73.86% in one year.
Market Cap
3.03M
Enterprise Value
70.72M
Revenue
53.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.10
Market Cap Chart
Since November 5, 2019, Centogene's market cap has decreased from 3.22M to 3.03M, a decrease of -5.83%. That is a compound annual growth rate of -1.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 3.03M | -22.89% |
| Dec 31, 2024 | 3.93M | -88.24% |
| Dec 29, 2023 | 33.44M | 32.77% |
| Dec 30, 2022 | 25.19M | -78.60% |
| Dec 31, 2021 | 117.70M | -50.06% |
| Dec 31, 2020 | 235.67M | 17.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 678.14M |
| Elite Pharmaceuticals | 677.87M |
| Veradigm | 500.94M |
| Northwest Biotherapeutics | 368.34M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 324.84M |
| American Oncology Network | 287.67M |
| Silence Therapeutics | 247.98M |